|
| 36594261 | Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages. | Emerg Microbes Infect | 2023 |
| 38082099 | SARS-COV-2 Omicron variants conformationally escape a rare quaternary antibody binding mode. | Commun Biol | 2023 |
| 37114433 | Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism. | Emerg Microbes Infect | 2023 |
| 37075076 | CMPK2 restricts Zika virus replication by inhibiting viral translation. | PLoS Pathog | 2023 |
| 36473500 | Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster. | Nat Med | 2023 |
| 36905944 | AT-752 targets multiple sites and activities on the Dengue virus replication enzyme NS5. | Antiviral Res | 2023 |
| 35140233 | Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection. | Nat Commun | 2022 |
| 35739094 | Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine. | Nat Commun | 2022 |
| 35550680 | Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant. | Cell Rep | 2022 |
| 35792746 | Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection. | Emerg Microbes Infect | 2022 |
| 35396516 | BNT162b2-elicited neutralization of Delta plus, Lambda, Mu, B.1.1.519, and Theta SARS-CoV-2 variants. | NPJ Vaccines | 2022 |
| 35746682 | A Single-Round Infection Fluorescent SARS-CoV-2 Neutralization Test for COVID-19 Serological Testing at a Biosafety Level-2 Laboratory. | Viruses | 2022 |
| 35618703 | Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2. | Nat Commun | 2022 |
| 36138032 | Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth. | Nat Commun | 2022 |
| 35988543 | Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein. | Cell Host Microbe | 2022 |
| 35896528 | A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions. | Nat Commun | 2022 |
| 36229471 | Publisher Correction: A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions. | Nat Commun | 2022 |
| 35132410 | Engineering SARS-CoV-2 cocktail antibodies into a bispecific format improves neutralizing potency and breadth. | bioRxiv | 2022 |
| 35316659 | Viperin triggers ribosome collision-dependent translation inhibition to restrict viral replication. | Mol Cell | 2022 |
| 35216328 | An Essential Role for Alzheimer's-Linked Amyloid Beta Oligomers in Neurodevelopment: Transient Expression of Multiple Proteoforms during Retina Histogenesis. | Int J Mol Sci | 2022 |
| 35245438 | Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2. | Cell Host Microbe | 2022 |
| 33469576 | Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera. | Res Sq | 2021 |
| 33657175 | Inhibition of innate immune response ameliorates Zika virus-induced neurogenesis deficit in human neural stem cells. | PLoS Negl Trop Dis | 2021 |
| 33684280 | Neutralizing Activity of BNT162b2-Elicited Serum. | N Engl J Med | 2021 |
| 33848289 | Correction: Role of microglia in the dissemination of Zika virus from mother to fetal brain. | PLoS Negl Trop Dis | 2021 |
| 33558724 | Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera. | Nat Med | 2021 |
| 33532771 | Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K, and N501Y variants by BNT162b2 vaccine-elicited sera. | bioRxiv | 2021 |
| 33691138 | A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence. | Cell | 2021 |
| 33501436 | A <i>trans</i> -complementation system for SARS-CoV-2. | bioRxiv | 2021 |
| 34617885 | Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective. | Elife | 2021 |
| 34525276 | SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3. | N Engl J Med | 2021 |
| 34462752 | Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant. | bioRxiv | 2021 |
| 34845215 | Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies. | NPJ Vaccines | 2021 |
| 34131306 | Author Correction: Spike mutation D614G alters SARS-CoV-2 fitness. | Nature | 2021 |
| 33979486 | BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants. | N Engl J Med | 2021 |
| 34111888 | BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants. | Nature | 2021 |
| 33106671 | Spike mutation D614G alters SARS-CoV-2 fitness. | Nature | 2021 |
| 33473190 | Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response. | Cell Mol Immunol | 2021 |
| 33442691 | Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera. | bioRxiv | 2021 |
| 32979938 | Evasion of Type I Interferon by SARS-CoV-2. | Cell Rep | 2020 |
| 33337934 | Antagonism of Type I Interferon by Severe Acute Respiratory Syndrome Coronavirus 2. | J Interferon Cytokine Res | 2020 |
| 32747564 | A Zika virus envelope mutation preceding the 2015 epidemic enhances virulence and fitness for transmission. | Proc Natl Acad Sci U S A | 2020 |
| 32628667 | Role of microglia in the dissemination of Zika virus from mother to fetal brain. | PLoS Negl Trop Dis | 2020 |
| 32935091 | Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility. | Res Sq | 2020 |
| 32908978 | Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility. | bioRxiv | 2020 |
| 32669438 | A cocrystal structure of dengue capsid protein in complex of inhibitor. | Proc Natl Acad Sci U S A | 2020 |
| 32641828 | Envelope protein ubiquitination drives entry and pathogenesis of Zika virus. | Nature | 2020 |
| 30958095 | Genetic and biochemical characterizations of Zika virus NS2A protein. | Emerg Microbes Infect | 2019 |
| 31662457 | Zika Virus NS2A-Mediated Virion Assembly. | mBio | 2019 |
| 29379028 | An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction. | Nat Commun | 2018 |